Archive: 02/12/2014

Otsuka to buy US drugmaker Avanir for $3.5B

Otsuka Pharmaceutical will spend $3.5 billion in cash to buy Avanir Pharmaceuticals in a deal that expands the Japanese drugmaker's portfolio of neurologic disease treatments.

page 7 from 10